720 related articles for article (PubMed ID: 16713366)
1. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
2. The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):476-90. PubMed ID: 16697269
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of ouabain on the vasodilator actions of nitric oxide and S-nitrosothiols in vivo: relevance to the identity of EDRF/EDHF.
Lewis SJ; Travis MD; Hashmi-Hill MP; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Dec; 45(6):383-94. PubMed ID: 16861050
[TBL] [Abstract][Full Text] [Related]
4. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
5. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
[TBL] [Abstract][Full Text] [Related]
7. Vasodilator actions of the endothelium-derived relaxing factor L-S-nitrosocysteine in anaesthetized rats are markedly diminished by peroxynitrite.
Graves JE; Bates JN; Kooy NW; Lewis SJ
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1137-41. PubMed ID: 16445582
[TBL] [Abstract][Full Text] [Related]
8. Cilazapril reverses endothelium-dependent vasodilator response to acetylcholine in mesenteric artery from spontaneously hypertensive rats.
Young RH; Ding YA; Lee YM; Yen MH
Am J Hypertens; 1995 Sep; 8(9):928-33. PubMed ID: 8541009
[TBL] [Abstract][Full Text] [Related]
9. Role of voltage-sensitive calcium-channels in nitric oxide-mediated vasodilation in spontaneously hypertensive rats.
Lewis SJ; Bhopatkar MY; Walton TM; Bates JN
Eur J Pharmacol; 2005 Dec; 528(1-3):144-9. PubMed ID: 16321377
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
11. Blockade of voltage-sensitive Ca(2+)-channels markedly diminishes nitric oxide- but not L-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo.
Travis MD; Hoque A; Bates JN; Lewis SJ
Eur J Pharmacol; 2000 Nov; 408(3):289-98. PubMed ID: 11090646
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide inhibits acetylcholine- and nitric oxide-mediated vasodilation in vivo.
Peters TS; Lewis SJ
J Pharmacol Exp Ther; 1996 Nov; 279(2):918-25. PubMed ID: 8930200
[TBL] [Abstract][Full Text] [Related]
14. Effects of endothelium-derived hyperpolarizing factor and nitric oxide on endothelial function in femoral resistance arteries of spontaneously hypertensive rats.
Mori Y; Ohyanagi M; Koida S; Ueda A; Ishiko K; Iwasaki T
Hypertens Res; 2006 Mar; 29(3):187-95. PubMed ID: 16755154
[TBL] [Abstract][Full Text] [Related]
15. Effects of enalapril and hydralazine treatment and withdrawal upon cardiovascular hypertrophy in stroke-prone spontaneously hypertensive rats.
King RA; Smith RM; Krishnan R; Cleary EG
J Hypertens; 1992 Sep; 10(9):919-28. PubMed ID: 1328373
[TBL] [Abstract][Full Text] [Related]
16. Flavin adenine dinucleotide may release preformed stores of nitrosyl factors from the vascular endothelium of conscious rats.
Hashmi-Hill MP; Sandock K; Bates JN; Robertson TP; Lewis SJ
J Cardiovasc Pharmacol; 2007 Aug; 50(2):142-54. PubMed ID: 17703130
[TBL] [Abstract][Full Text] [Related]
17. Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.
Liu YH; Liu LY; Wu JX; Chen SX; Sun YX
J Cardiovasc Pharmacol; 2006 Jan; 47(1):82-8. PubMed ID: 16424790
[TBL] [Abstract][Full Text] [Related]
18. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
Lappe RW; Todt JA; Wendt RL
J Pharmacol Exp Ther; 1985 Dec; 235(3):651-6. PubMed ID: 3001271
[TBL] [Abstract][Full Text] [Related]
19. Peroxynitrite elicits dysfunction of stereoselective s-nitrosocysteine recognition sites.
Lewis SJ; Graves JE; Bates JN; Kooy NW
J Cardiovasc Pharmacol; 2005 Nov; 46(5):637-45. PubMed ID: 16220071
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of hydralazine and captopril on the cardiovascular changes in spontaneously hypertensive rats.
Limas C; Westrum B; Limas CJ
Am J Pathol; 1984 Dec; 117(3):360-71. PubMed ID: 6391187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
